Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001818382-22-000022
Filing Date
2022-04-05
Accepted
2022-04-05 16:38:00
Documents
2
Period of Report
2022-04-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_164919106245652.html 3  
1 FORM 3 wf-form3_164919106245652.xml 3 1741
2 POA DOCUMENT - SJP ex-24.htm EX-24 3358
  Complete submission text file 0001818382-22-000022.txt   6562
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Issuer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1160 HEDGEROW DRIVE GARNET VALLEY PA 19060
Business Address
Parikh Shamik J (Reporting) CIK: 0001916853 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39532 | Film No.: 22807543